Target intelligence / Profile preview

Influenza hemagglutinin globular head domain (HA head domain)

Target
HA head domain
Molecular classification
Viral envelope protein domain, Receptor-binding domain, Antigenic domain
01

Overview

The **hemagglutinin globular head domain** is a structurally distinct region of the influenza virus hemagglutinin (HA) protein, found at the tip of each HA monomer that forms the viral spike. It is composed mainly of the N-terminal HA1 subunit and is responsible for binding to sialic acid-containing receptors on the surface of host cells, which is crucial for viral attachment and entry. The head domain is the primary target of neutralizing antibodies and is a major focus of seasonal and pandemic influenza vaccine strategies. However, it is also subject to frequent antigenic drift, enabling the virus to evade immunity developed against previous strains. Its functional and immunogenic importance make the HA head domain a central target for both vaccine design and therapeutic antibodies in influenza infection[1][2][4][6][7][8].

Other names
Hemagglutinin head domainHA1 headinfluenza hemagglutinin receptor-binding domainHA globular head
02

Mechanism of action

Neutralizing antibodies prevent viral entry by blocking sialic acid binding Inhibitors and antibodies may prevent attachment to host cell or accelerate clearance by immune system

03

Biological functions

Virus attachment to host cell (receptor binding)Major antigenic site for immune responseMediating host range specificity
04

Disease associations

Infection (influenza virus)Immune evasion (through antigenic drift)Key determinant in vaccine efficacy
05

Safety considerations

High mutation rate (antigenic drift) leads to escape from pre-existing immunity and reduced vaccine effectivenessVariable immune response due to antigenic variation among strains
06

Interacting drugs

Influenza vaccines (seasonal and pandemic, e.g., H1N1, H3N2, H5N1, H7N9 vaccines)

2 more in the full profile.

07

Biomarkers

Presence of anti-HA head domain antibodies as a correlate of protectionMutations in antigenic sites as markers of vaccine escape or antigenic drift

Beyond the preview

Go deeper on Influenza hemagglutinin globular head domain (HA head domain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza hemagglutinin globular head domain (HA head domain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call